Topical Ammonia-Oxidizing Bacteria for Antibiotic-Resistant Acne
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for acne are either marginally effective or associated with serious risks, and there is a need for a safe, effective, and non-resistance-inducing topical therapy that can reduce lesion frequency, duration, inflammation, and sebum production, while also decreasing pathogenic bacteria presence.
Innovation Solution
Topical administration of ammonia oxidizing bacteria, such as Nitrosomonas eutropha, which reduces pathogenic bacteria like Propionibacterium acnes, inflammation, and sebum production, and improves skin condition by applying a therapeutically effective dose in a self-administered, odorless, and non-toxic formulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional acne treatments (topical antibiotics, oral antibiotics, retinoids) are used, then acne lesions are targeted, but antibiotic resistance is fostered and serious risks are associated
Solution Approach 1:
The patent applies ammonia oxidizing bacteria that convert ammonia (a byproduct of sebum breakdown) into nitrite, which has antibacterial properties. This converts a harmful substance (ammonia that promotes pathogenic bacteria growth) into a beneficial antimicrobial agent (nitrite) that suppresses Propionibacterium acnes without inducing resistance
Solution Approach 2:
The patent introduces ammonia oxidizing bacteria as an intermediary organism that mediates between ammonia and pathogenic bacteria. These bacteria consume ammonia and produce nitrite, which then acts as the actual antimicrobial agent against P. acnes, providing indirect protection without direct antibiotic exposure
2Object-affected harmful factors
If topical antibiotics and retinoids are applied, then acne lesions are treated, but the treatments are marginally effective and associated with serious risks
Solution Approach 1:
The ammonia oxidizing bacteria are applied topically and autonomously perform the therapeutic function by metabolizing ammonia to nitrite. The bacteria self-regulate their population and metabolic activity based on environmental conditions (ammonia availability, pH, temperature), providing self-adjusting treatment without requiring complex dosage management
Solution Approach 2:
The patent changes the biochemical parameters of the skin environment by introducing bacteria that alter ammonia concentration and nitrite production. This creates a new therapeutic parameter (nitrite concentration) that provides antibacterial activity with a different safety profile compared to traditional antibiotics and retinoids
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively treats inflammatory and non-inflammatory acne lesions, reduces inflammation, frequency, and sebum production, and improves skin condition without fostering antibiotic resistance, as demonstrated by clinical grading and patient quality-of-life surveys.
Implementation Method 1
ammonia oxidizing bacteria, e.g., a preparation comprising ammonia oxidizing bacteria
Data Source
AI summary
A method for treating a skin disorder, e.g., acne, e.g. acne vulgaris, in a subject is provided. The method comprises administering, e.g., applying, e.g., topically administering, ammonia oxidizing bacteria, e.g., a preparation comprising ammonia oxidizing bacteria, to a surface of the subject. Preparations comprising ammonia oxidizing bacteria for treating such skin disorder, e.g., acne, e.g. acne vulgaris in a subject are also provided.